Lv1
50 积分 2024-11-05 加入
Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer’s Disease
28天前
已完结
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase
28天前
已完结
Emerging role of Metformin in Alzheimer’s disease: A translational view
1个月前
已完结
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
1个月前
已完结
The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New Developments
1个月前
已完结
A Review of Sotagliflozin: The First Dual SGLT-1/2 Inhibitor
1个月前
已完结
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
1个月前
已完结
Sotagliflozin: Efficacy, Safety, and Potential Therapeutic Applications in Heart Failure
1个月前
已完结
A Review of the Potential Role of Sotagliflozin: A Dual SGLT2 and SGLT1 Inhibitor—in the Treatment of Heart Failure
1个月前
已完结
The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New Developments
1个月前
已完结
皖公网安备34019202002308
